NCT04535752View on ClinicalTrials.gov

A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

June 26, 2021

Study Completion Date

June 26, 2021

Conditions

Safety and Tolerability in Healthy Volunteers

Interventions

DRUG

ANX009

Single or multiple ascending dose

DRUG

Placebo

Single or multiple ascending dose

Trial Locations (1)

Unknown

Site 1, Melbourne

Sponsors

Collaborators (1)

Nucleus Network Ltd

All Listed Sponsors

collaborator

Nucleus Network Ltd

OTHER

lead

Annexon, Inc.

INDUSTRY